Changes in Serum Levels of sTREM-1,sCD14,and LBP in Elderly Patients with Liver Cirrhosis and Bacterial Peritonitis and their Impact on Patient Prognosis
WANG Ping, TIAN Pengfei, ZHOU Ming
The Xinxiang Public Health Medical Treatment Center,Henan Xinxiang 453000
Abstract：【Objective】To investigate the changes in sTREM-1,sCD14,and lipopolysaccharide binding protein (LBP) in elderly patients with liver cirrhosis complicated with bacterial peritonitis (SBP).【Methods】A total of 108 elderly patients with liver cirrhosis and SBP admitted to our center and Xinxiang Central Hospital from August 2020 to March 2022 were selected as the observation group,while 108 elderly patients with liver cirrhosis without SBP were selected as the control group. According to the prognosis after 9-12 days of treatment,patients in the observation group were divided into a poor prognosis group (n=38) and a good prognosis group (n=70). The serum levels of sTREM-1,sCD14,and LBP were compared among different groups of patients before treatment,and logistic regression analysis was used to analyze the risk factors of elderly cirrhosis with SBP.【Results】Before treatment,the serum levels of sTREM-1,sCD14,and LBP in the observation group were higher than those in the control group,with statistically significant differences (P<0.05). Logistic regression analysis showed that serum sTREM-1>55.49 μg/mL,sCD14>24.94 mg/L,and LBP >90.79 μg/L before treatment were risk factors for elderly cirrhosis with SBP (P<0.05). After treatment,the serum levels of sTREM-1,sCD14,and LBP in the group with good prognosis were lower than before treatment (P<0.05),while those in the group with poor prognosis were higher than those in the group with good prognosis (P<0.05). The risk of poor prognosis in patients with high levels of serum sTREM-1,sCD14,and LBP in patients with cirrhosis and SBP was 2.116 times,2.992 times,and 2.088 times higher than that in patients with low levels (P<0.05).【Conclusion】Abnormal elevation of serum levels of sTREM-1,sCD14,and LBP can induce cirrhosis with SBP. Detecting their expression levels can provide a reference for clinical prediction of prognosis in patients with cirrhosis with SBP.
王平, 田鹏飞, 周明. 老年肝硬化合并细菌性腹膜炎患者血清sTREM-1、sCD14、LBP水平变化及其对患者预后的影响[J]. 医学临床研究, 2023, 40(9): 1339-1341.
WANG Ping, TIAN Pengfei, ZHOU Ming. Changes in Serum Levels of sTREM-1,sCD14,and LBP in Elderly Patients with Liver Cirrhosis and Bacterial Peritonitis and their Impact on Patient Prognosis. JOURNAL OF CLINICAL RESEARCH, 2023, 40(9): 1339-1341.
[1] 刘玉玲,甄增国,王慧娟,等.益生菌制剂对肝硬化并发自发性细菌性腹膜炎患者肠道屏障功能的影响[J].实用肝脏病杂志,2021,24(6):867-870. [2] TU B,ZHANG Y N,BI J F,et al. Multivariate predictive model for asymptomatic spontaneous bacterial peritonitis in patients with liver cirrhosis[J].World J Gastroenterol,2020,26(29):4316-4326. [3] 杨帆,冯亚民,齐良刚.血清炎性指标与内毒素及sTREM-1在肺癌患者术后肺部感染中的临床意义[J].中华医院感染学杂志,2019,29(19):2916-2920. [4] FRENCH A L,GRENNAN D,DAUBERT E,et al. Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/hepatitis C virus coinfected women[J].AIDS,2021,35(9):1433-1438. [5] 中华医学会肝病学分会.肝硬化诊治指南[J].中华肝脏病杂志,2019,27(11):846-865. [6] 中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南[J].实用肝脏病杂志,2018,21(1):21-31. [7] 王菁,毕宁,方亮,等.乙型肝炎肝硬化并发自发性细菌性腹膜炎患者CD64指数及血清sTREM-1和IL-6水平变化与肠黏膜屏障功能关系研究[J].实用肝脏病杂志,2022,25(1):79-82. [8] 李杰,张莉.sTREM-1含量、血降钙素原和C-反应蛋白在肝硬化腹水非多形核细胞性自发性细菌性腹膜炎的诊断意义[J].中国中西医结合消化杂志,2019,27(6):456-460. [9] 公建庄,杜晨旭,吴慧丽.PGRN/Alb、sTREM-1、LBP指标诊断肝硬化细菌性腹膜炎价值及对疗效影响[J].分子诊断与治疗杂志,2021,13(9):1410-1413. [10] 谭文敏,赖庭文,韩锋.CD64指数、sTREM-1、IL-6联合检测对肝硬化合并自发性细菌性腹膜炎的诊断价值[J].中国病毒病杂志,2019,9(5):383-388. [11] 贺晓蕾,徐雪英,王丽莹.sCD14、hs-CRP、HNL对CRF腹膜透析细菌性腹膜炎诊断价值及意义[J].分子诊断与治疗杂志,2021,13(7):1080-1083. [12] FERRARESE A,FRIGO A C,MION M M,et al. Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection[J].Clin Chem Lab Med,2020,59(4):775-782. [13] 黎秋芬,方祎,王曲倔,等.PCT、CRP、腹水乳铁蛋白及LBP联合检测在自发性细菌性腹膜炎患者诊断中的临床价值[J].标记免疫分析与临床,2019,26(3):477-480.
2023, Vol. 40 
